Enterprise Financial Services Corp Zai Lab LTD Transaction History

Enterprise Financial Services Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$105.0 - $178.37 $13,125 - $22,296	-125 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $1,000 - $1,440	8 Added 6.84%	125 $22,000
Q1 2021 May 13, 2021	BUY	$126.27 - $191.71 $4,545 - $6,901	36 Added 44.44%	117 $16,000
Q2 2020 Aug 04, 2020	BUY	$48.82 - $82.53 $1,269 - $2,145	26 Added 47.27%	81 $7,000
Q1 2020 May 15, 2020	BUY	$39.1 - $62.9 $2,150 - $3,459	55 New	55 $3,000

116

40.8M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.